Impact of common disinfectants used in Ecuadorian hospitals on Candida spp
Main Article Content
Abstract
Introduction. Nosocomial infections caused by fungal pathogens such as Candida spp. represent a critical challenge in healthcare. Given the limited experimental data in Ecuador on the efficacy of biocides against fungi, this study evaluated the impact of commonly used disinfectants. Objective. To evaluate the impact of the biological efficacy and temporal stability of commonly used disinfectants in Ecuadorian hospitals on the control of the in vitro growth of Candida spp. At 24 and 48 hours of incubation. Methodology. A quantitative, experimental in vitro study was conducted using Candida albicans ATCC 10231. Potassium monopersulfate (1%), sodium hypochlorite (2%), quaternary ammonium (1.23%), povidone-iodine (10%), enzymatic detergent (1% v/v), and a glutaraldehyde gradient (50%, 25%, and 10%) were evaluated. Efficacy was measured by net inhibition zones on Sabouraud agar at 24 and 48 hours. Results. At 24 hours, potassium monopersulfate (26.0 mm) and sodium hypochlorite (22.0 mm) showed the greatest fungicidal efficacy. Glutaraldehyde showed concentration-dependent activity (22.0 mm at 50%), while quaternary ammonium and povidone-iodine exhibited minimal inhibition. At 48 hours, the inhibition zones had decreased, highlighting the stability of sodium hypochlorite, potassium monopersulfate, and 50% glutaraldehyde. Conclusion. Oxidizing agents, specifically 2% sodium hypochlorite and 1% potassium monopersulfate, are first-choice alternatives for disinfecting critical hospital areas against Candida spp. General Area of Study: General field of study: Biochemistry and Pharmacy (Health Sciences). Specific area of study: Microbiology. Type of study: Original article.
Downloads
Article Details
References
2. World Health Organization [WHO] [Internet]. WHO fungal priority pathogens list to guide research, development and public health action. 2022 [cited 2026 June 2]. Available from: https://iris.who.int/handle/10665/363682
3. McCarty TP, White CM, Pappas PG. Candidemia and invasive candidiasis. Infectious Disease Clinics of North America [Internet]. 2021 [cited 2026 June 2];35(2):389–413. Available from: http://dx.doi.org/10.1016/j.idc.2021.03.007
4. Nucci M, Queiroz-Telles F, Alvarado-Matute T, Tiraboschi IN, Cortes J, Zurita J, et al. Epidemiology of candidemia in Latin America: a laboratory-based survey. PLoS One [Internet]. 2013 [cited 2026 June 2];8(3): e59373. Available from: http://dx.doi.org/10.1371/journal.pone.0059373
5. Atiencia-Carrera MB, Cabezas-Mera FS, Tejera E, Machado A. Prevalence of biofilms in Candida spp. bloodstream infections: a meta-analysis. PLoS One [Internet]. 2022 [cited 2026 June 2];17(2): e0263522. Available from: http://dx.doi.org/10.1371/journal.pone.0263522
6. Arafa SH, Elbanna K, Osman GEH, Abulreesh HH. Candida diagnostic techniques: a review. Journal of Umm Al-Qura University for Applied Sciences [Internet]. 2023 [cited 2026 June 2];9(3):360–377. Available from: http://dx.doi.org/10.1007/s43994-023-00049-2
7. Omardien S, Teska P. Skin and hard surface disinfection against Candida auris - What we know today. Frontiers in Medicine (Lausanne) [Internet]. 2024 [cited 2026 June 2]; 11:1312929. Available from: http://dx.doi.org/10.3389/fmed.2024.1312929
8. World Health Organization [WHO] [Internet]. Decontamination and reprocessing of medical devices for health-care facilities. 2016 [cited 2026 June 2]. Available from: https://iris.who.int/handle/10665/250233
9. Maillard JY, Centeleghe I. How biofilm changes our understanding of cleaning and disinfection. Antimicrobial Resistance & Infection Control [Internet]. 2023 [cited 2026 June 2];12(1):95. Available from: http://dx.doi.org/10.1186/s13756-023-01290-4
10. Bandara HMHN, Samaranayake LP. Emerging strategies for environmental decontamination of the nosocomial fungal pathogen Candida auris. Journal of Medical Microbiology [Internet]. 2022 [cited 2026 June 2];71(6). Available from: http://dx.doi.org/10.1099/jmm.0.001548
11. Edner A, Lindström-Nilsson M, Melhus Low risk of transmission of pathogenic bacteria between children and the assistance dog during animal-assisted therapy if strict rules are followed. Journal of Hospital Infection [Internet]. 2021 [cited 2026 June 2]; 115:5–9. Available from: http://dx.doi.org/10.1016/j.jhin.2021.04.025
12. Balouiri M, Sadiki M, Ibnsouda SK. Methods for in vitro evaluating antimicrobial activity: A review. Journal of Pharmaceutical Analysis [Internet]. 2016 [cited 2026 June 2];6(2):71–79. Available from: http://dx.doi.org/10.1016/j.jpha.2015.11.005
13. McDonnell G, Russell AD. Antiseptics and disinfectants: activity, action, and resistance. Clinical microbiology reviews [Internet]. 1999 [cited 2026 June 2];12(1):147–179. Available from: https://pubmed.ncbi.nlm.nih.gov/9880479/
14. Gajic I, Kabic J, Kekic D, Jovicevic M, Milenkovic M, Mitic Culafic D, et al. Antimicrobial susceptibility testing: A comprehensive review of currently used methods. Antibiotics (Basel) [Internet]. 2022 [cited 2026 June 2];11(4):427. Available from: http://dx.doi.org/10.3390/antibiotics11040427
15. Rutala WA, Weber DJ. Guideline for Disinfection and Sterilization in Healthcare Facilities, 2008 [Internet]. 2019 [cited 2026 June 2]. Available from: https://stacks.cdc.gov/view/cdc/134910?utm_
16. CDC Infection Control [Internet]. Chemical disinfectants from the guideline for disinfection and sterilization in healthcare facilities (2008). 2023 Nov. [cited 2026 June 2]. Available from: https://www.cdc.gov/infection-control/hcp/disinfection-sterilization/chemical-disinfectants.html
17. Callender SP, Wettig SD. Phase behavior of non‐ionic surfactant‐medium chain triglyceride‐water microemulsion systems. Journal of Surfactants and Detergents [Internet]. 2021 [cited 2026 June 2];24(4):603–629. Available from: http://dx.doi.org/10.1002/jsde.12510
18. World Health Organization [WHO] [Internet]. Global guidelines for the prevention of surgical site infection. 2016 [cited 2026 June 2]. Available from: https://www.who.int/publications/b/47483
19. Guarner J, Brandt ME. Histopathologic diagnosis of fungal infections in the 21st century. Clinical Microbiology Reviews [Internet]. 2011 [cited 2026 June 2];24(2):247–280. Available from: http://dx.doi.org/10.1128/CMR.00053-10
20. Zmarlak-Feher NM, Finke A, Konrat K, Schaudinn C, Arvand M, Richter AM. Disinfectant tolerance of Candidozyma auris and Candida albicans biofilms evaluated using the bead assay for biofilms. Microbiology Spectrum [Internet]. 2026 [cited 2026 June 2];14(8): e0358225. Available from: http://dx.doi.org/10.1128/spectrum.03582-25
21. Krishnan CS, Milne TJ, Tompkins GR, Cannon RD, Lamping E. Molecular mechanism of action of HOCl from neutral-pH electrolysed oxidising water against Candida albicans. Journal of Fungi (Basel) [Internet]. 2025 [cited 2026 June 2];11(11):761. Available from: http://dx.doi.org/10.3390/jof11110761
22. Dantas A da S, Day A, Ikeh M, Kos I, Achan B, Quinn J. Oxidative stress responses in the human fungal pathogen, Candida albicans. Biomolecules [Internet]. 2015 [cited 2026 June 2];5(1):142–165. Available from: http://dx.doi.org/10.3390/biom5010142
23. Putri YA, Pratiwi RH, Mangunwardoyo W. Disruption of hyphal development in Candida albicans ATCC 10231 by bioactive compound from Pseudomonas azotoformans UICC B-91. Journal of Applied Pharmaceutical Science [Internet]. 2023 [cited 2026 June 2]. Available from: https://japsonline.com/admin/php/uploads/4122_pdf.pdf
24. Hong J-Y, Moon YG, Choi SK, Kim HT, Jo S. Povidone iodine demonstrates strong efficacy in reducing Candida biofilm in an in vitro fungal prosthetic infection. Scientific Reports [Internet]. 2026 [cited 2026 June 2];16(1). Available from: http://dx.doi.org/10.1038/s41598-026-42366-6